These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-007027-40 A Multicenter open-label, phase I/II dose escalation study of oral lapatinib in combination with docetaxel in patients with HER2 positive advanced or metastatic breast cancer not-yet-due
Ongoing 2008-002775-28 Evaluation de l'association irinotécan/bévacizumab utilisée en néo-adjuvant et en adjuvant d'une radiochimiothérapie avec témozolomide concomitant pour les glioblastomes non résécables. Etude de phase... not-yet-due
Not reported 2010-018572-25 Carcinomes Oesophagiens Non opérés traités par Chimioradiothérapie à base d’Oxaliplatine (FOLFOX-4) et Radiothérapie à Dose Elevée (CONCORDE) : Essai de phase II-III 2023-11-27 due-trials
Ongoing 2015-004108-44 PREMETHEP : Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an early predictive factor of overall survival in patients with advanced hepa... not-yet-due
Ongoing 2016-002552-24 Pemetrexed (Alimta®) in maintenance in patients with impaired renal function: multicenter randomized Phase 4 study comparing two strategies for dose calculation Pemetrexed (Alimta®) en maintenance ... not-yet-due
Other 2018-002971-17 Precision medicine phase II study evaluating the efficacy of a double immunotherapy by Durvalumab and Tremelimumab combined with Olaparib in patients with solid cancers and carriers of homologous reco... not-yet-due
Other 2019-003627-38 18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma 18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/C... not-yet-due